enGene Holdings (ENGN) Company Overview

Profile

Full Name:

enGene Holdings Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Canada

IPO:

February 1, 2022

Indexes:

Not included

Description:

enGene Holdings is a biotechnology company focused on developing innovative gene therapies. They aim to treat various diseases by using their proprietary technology to deliver genes directly to target cells, improving patient outcomes and advancing healthcare solutions. Their work emphasizes safety and effectiveness in gene-based treatments.

Events Calendar

Earnings

Next earnings date:

Mar 11, 2025

Recent quarterly earnings:

Dec 19, 2024

Recent annual earnings:

Dec 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 18, 25 Piper Sandler
Overweight
Feb 14, 25 UBS
Neutral
Dec 23, 24 JMP Securities
Market Outperform
Dec 23, 24 HC Wainwright & Co.
Buy
Dec 6, 24 JMP Securities
Market Outperform
Nov 27, 24 Raymond James
Outperform
Nov 18, 24 JMP Securities
Market Outperform
Sep 24, 24 Oppenheimer
Outperform
Sep 11, 24 Morgan Stanley
Overweight
Aug 28, 24 Oppenheimer
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for enGene Holdings?
  • Does enGene Holdings pay dividends?
  • What sector is enGene Holdings in?
  • What industry is enGene Holdings in?
  • What country is enGene Holdings based in?
  • When did enGene Holdings go public?
  • Is enGene Holdings in the S&P 500?
  • Is enGene Holdings in the NASDAQ 100?
  • Is enGene Holdings in the Dow Jones?
  • When was enGene Holdings's last earnings report?
  • When does enGene Holdings report earnings?
  • Should I buy enGene Holdings stock now?

What is the ticker symbol for enGene Holdings?

The ticker symbol for enGene Holdings is NASDAQ:ENGN

Does enGene Holdings pay dividends?

No, enGene Holdings does not pay dividends

What sector is enGene Holdings in?

enGene Holdings is in the Healthcare sector

What industry is enGene Holdings in?

enGene Holdings is in the Biotechnology industry

What country is enGene Holdings based in?

enGene Holdings is headquartered in Canada

When did enGene Holdings go public?

enGene Holdings's initial public offering (IPO) was on February 1, 2022

Is enGene Holdings in the S&P 500?

No, enGene Holdings is not included in the S&P 500 index

Is enGene Holdings in the NASDAQ 100?

No, enGene Holdings is not included in the NASDAQ 100 index

Is enGene Holdings in the Dow Jones?

No, enGene Holdings is not included in the Dow Jones index

When was enGene Holdings's last earnings report?

enGene Holdings's most recent earnings report was on Dec 19, 2024

When does enGene Holdings report earnings?

The next expected earnings date for enGene Holdings is Mar 11, 2025

Should I buy enGene Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions